ALFA Filings
Every announcement, straight from the exchange
Every Aspira Pathlab & Diagnostics open offer announcement on NSE and BSE, newest first, each with its own page.
Time
3 announcements
Promoter group acquired 22.18% stake in Aspira Pathlab via an open offer. This increases their holding to 46%, signaling consolidation of control.
Aspira Pathlab & Diagnostics Ltd's Independent Director Committee has recommended an Open Offer for the acquisition of 26,76,180 shares (26% stake) at ₹55 per share. The ₹14.72 Crore offer is led by Mr. Arvind Karsandas Bhanushali and others. The IDC considers the offer fair and reasonable based on SEBI valuation parameters.
Arvind Karsandas Bhanushali and others have launched an open offer to acquire a 26% stake in Aspira Pathlab & Diagnostics Limited at ₹55 per share. The total offer size is ₹14.72 Crore. The tendering period is scheduled from April 15 to April 28, 2026, following a substantial acquisition and change in control.